Skip to content

Clinical trials

Terminated Carcinoma, Hepatocellular trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Terminated Country / region: Taiwan Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20082
20092
20103
20114
20121
20142
20162
20171
20182
20192
20201
20212
20223
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Taiwan Liposome Company3
Bristol-Myers Squibb2
National Health Research Institutes, Taiwan2
Novartis Pharmaceuticals2
Abbott1
Adherex Technologies, Inc.1
Antengene Therapeutics Limited1
Astellas Pharma Inc1
Cellxpert Biotechnology Corp.1
Chang Gung Memorial Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular34
Neoplasms7
Liver Neoplasms5
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Melanoma2
Neoplasm Metastasis2
Stomach Neoplasms2
Adenocarcinoma1
Carcinoma1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.